Retagliptin Phosphate
Retagliptin Phosphate (SP 2086) is a small molecule DPP-4 inhibitor used in research for type 2 diabetes. It is applied in both in vitro enzymatic assays and in vivo animal studies to investigate mechanisms of glycemic control and incretin hormone potentiation.
Product Specifications
CAS Number
1256756-88-3
Product Name Alternative
GLP-1, Inhibitor, inhibit, DPP, DPP-4, DPP4, Dipeptidyl Peptidase, Retagliptin, Retagliptin Phosphate, T2DM, SP2086, SP-2086, SP 2086
Field of Research
Protein Biochemistry
Purity
98.70% (May vary between batches)
Solubility
DMSO:≥ 150 mg/mL (266.73 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.56 mM)
Smiles
P (=O) (O) (O) O.C (OC) (=O) C1=C2N (C (C (F) (F) F) =N1) CCN (C (C[C@@H] (CC3=C (F) C=C (F) C (F) =C3) N) =O) C2
Molecular Formula
C19H21F6N4O7P
Molecular Weight
562.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K5004104 1.0 µg DNA
Zbtb49 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 